About
Team
Companies
News

Azure

About
Team
Companies
News
Gingko partners with Pfizer in its first drug discovery deal for RNA medicines
October 7, 2023
Ginkgo Bioworks
Azure Capital Partners
Gingko partners with Pfizer in its first drug discovery deal for RNA medicines
Azure Capital Partners
October 7, 2023
Ginkgo Bioworks

Gingko partners with Pfizer in its first drug discovery deal for RNA medicines

Azure Capital Partners
October 7, 2023
Ginkgo Bioworks

Source:https://www.fiercebiotech.com/biotech/pfizer-hooks-ginkgo-331m-biobucks-deal-unspecified-targets

Newer PostRanovus discusses the transformative impact of optics on AI with Canadian Prime Minister Justin Trudeau
Older PostNative Voice’s Powerful Voice-enabled AI Technology Will Elevate the TuneIn Experience on Skullcandy’s Skull-iQ Devices
Back to Top
Azure Capital Partners, 1050 Battery St., Unit 100, San Francisco, CA, 94111415-276-5500info@azurecap.com

San Francisco

Menlo Park

Miami

Calgary

t i

© 2022 Azure Capital Partners Terms of Use